# A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

> **NCT06110923** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 31 (actual)

## Conditions studied

- Benign Prostate Hypertrophy(BPH)

## Interventions

- **DRUG:** CKD-846
- **DRUG:** D091

## Key facts

- **NCT ID:** NCT06110923
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-13
- **Primary completion:** 2024-05-10
- **Final completion:** 2025-03-25
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06110923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06110923, "A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06110923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*